Eric W. J. Gates

Structure-activity relationships of N-terminal variants of peptidomimetic tissue transglutaminase inhibitors

Nicole M. R. McNeil, Eric W. J. Gates, Neda Firoozi et al. · European Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity

Ellen A. Rorke, Gautam Adhikary, Henryk Szmacinski et al. · Molecular Carcinogenesis · 2021 · 16 citations · Full text

Medicine, Biochemistry, Oncology +9

Structure–activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors

Alana M. M. Rangaswamy, Pauline Navals, Eric W. J. Gates et al. · RSC Medicinal Chemistry · 2022 · 16 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +13

Novel irreversible peptidic inhibitors of transglutaminase 2

Nicholas J. Cundy, Jane Arciszewski, Eric W. J. Gates et al. · RSC Medicinal Chemistry · 2022 · 12 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +4

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype

Eric W. J. Gates, Nicholas D. Calvert, Nicholas J. Cundy et al. · International Journal of Molecular Sciences · 2023 · 12 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11